{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:34:22Z","timestamp":1786984462688,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.antiviral.2019.104701","type":"journal-article","created":{"date-parts":[[2019,12,23]],"date-time":"2019-12-23T12:21:42Z","timestamp":1577103702000},"page":"104701","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein"],"prefix":"10.1016","volume":"174","author":[{"given":"Xiaoyu","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104701_bib1","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/JVI.00208-06","article-title":"Role of the stable signal peptide and cytoplasmic domain of G2 in regulating intracellular transport of the Junin virus envelope glycoprotein complex","volume":"80","author":"Agnihothram","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib2","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.1128\/JVI.02779-06","article-title":"Bitopic membrane topology of the stable signal peptide in the tripartite Junin virus GP-C envelope glycoprotein complex","volume":"81","author":"Agnihothram","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib3","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.antiviral.2019.104701_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.spen.2012.02.002","article-title":"Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult","volume":"19","author":"Bonthius","year":"2012","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.antiviral.2019.104701_bib5","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1074\/jbc.M110.166025","article-title":"Structure of a zinc-binding domain in the Junin virus envelope glycoprotein","volume":"286","author":"Briknarova","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104701_bib6","doi-asserted-by":"crossref","first-page":"10329","DOI":"10.1128\/JVI.01624-16","article-title":"Role of LAMP1 binding and pH sensing by the spike complex of lassa virus","volume":"90","author":"Cohen-Dvashi","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib7","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.jmb.2018.04.026","article-title":"Novel insights into cell entry of emerging human pathogenic arenaviruses","volume":"430","author":"Fedeli","year":"2018","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104701_bib8","series-title":"A). Cresemba Prescribing Information Vol. Reference ID 3712237","author":"Food and Drug Administration","year":"2015"},{"key":"10.1016\/j.antiviral.2019.104701_bib9","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1128\/CMR.12.4.501","article-title":"Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance","volume":"12","author":"Ghannoum","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.104701_bib10","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.3389\/fmicb.2018.01751","article-title":"Review of mammarenavirus biology and replication","volume":"9","author":"Hallam","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.antiviral.2019.104701_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.coviro.2018.05.002","article-title":"Lassa virus glycoprotein: stopping a moving target","volume":"31","author":"Hastie","year":"2018","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib12","doi-asserted-by":"crossref","first-page":"j2986","DOI":"10.1136\/bmj.j2986","article-title":"Lassa fever","volume":"358","author":"Houlihan","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.antiviral.2019.104701_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2174\/138955711793564051","article-title":"Recent advances and future perspectives of triazole analogs as promising antiviral agents","volume":"11","author":"Kharb","year":"2011","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104701_bib14","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/17512433.2016.1185361","article-title":"Isavuconazonium sulfate: a new agent for the treatment of invasive aspergillosis and invasive mucormycosis","volume":"9","author":"Kovanda","year":"2016","journal-title":"Expert Rev. Clin. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104701_bib15","doi-asserted-by":"crossref","first-page":"10768","DOI":"10.1128\/JVI.00941-08","article-title":"Identification of a broad-spectrum arenavirus entry inhibitor","volume":"82","author":"Larson","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007439","article-title":"A potent Lassa virus antiviral targets an arenavirus virulence determinant","volume":"14","author":"Madu","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104701_bib17","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s40265-015-0398-6","article-title":"Isavuconazonium: first global approval","volume":"75","author":"McCormack","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.antiviral.2019.104701_bib18","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.tim.2018.04.004","article-title":"Drug repurposing for viral infectious diseases: how far are we?","volume":"26","author":"Mercorelli","year":"2018","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.antiviral.2019.104701_bib19","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1128\/JVI.07241-11","article-title":"Dissection of the role of the stable signal peptide of the arenavirus envelope glycoprotein in membrane fusion","volume":"86","author":"Messina","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib20","doi-asserted-by":"crossref","first-page":"10924","DOI":"10.1128\/JVI.01587-15","article-title":"Identification and mechanism of action of a novel small-molecule inhibitor of arenavirus multiplication","volume":"89","author":"Ngo","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib21","series-title":"Weekly Epidemiological Report","author":"Nigeria Centre for Disease Control","year":"2018"},{"key":"10.1016\/j.antiviral.2019.104701_bib22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/v4010083","article-title":"The curious case of arenavirus entry, and its inhibition","volume":"4","author":"Nunberg","year":"2012","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2019.104701_bib23","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.antiviral.2017.11.011","article-title":"Antifungal azoles itraconazole and posaconazole exhibit potent in vitro antiviral activity against clinical isolates of parechovirus A3 (Picornaviridae)","volume":"149","author":"Rhoden","year":"2018","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104701_bib24","doi-asserted-by":"crossref","first-page":"W321","DOI":"10.1093\/nar\/gkh377","article-title":"The PredictProtein server","volume":"32","author":"Rost","year":"2004","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2019.104701_bib25","doi-asserted-by":"crossref","first-page":"6799","DOI":"10.1128\/JVI.00597-16","article-title":"Small-molecule fusion inhibitors bind the pH-sensing stable signal peptide-GP2 subunit interface of the lassa virus envelope glycoprotein","volume":"90","author":"Shankar","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib26","doi-asserted-by":"crossref","first-page":"23110","DOI":"10.1038\/srep23110","article-title":"Therapeutic and prophylactic activity of itraconazole against human rhinovirus infection in a murine model","volume":"6","author":"Shim","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.antiviral.2019.104701_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.celrep.2014.12.054","article-title":"Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein","volume":"10","author":"Strating","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.antiviral.2019.104701_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01902-16","article-title":"Lassa virus cell entry reveals new aspects of virus-host cell interaction","volume":"91","author":"Torriani","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib30","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s12250-016-3815-4","article-title":"Structure-function relationship of the mammarenavirus envelope glycoprotein","volume":"31","author":"Wang","year":"2016","journal-title":"Virol. Sin."},{"key":"10.1016\/j.antiviral.2019.104701_bib31","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00954-18","article-title":"Screening and identification of lassa virus entry inhibitors from an FDA-approved drug library","volume":"92","author":"Wang","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib32","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/tra.12389","article-title":"Fusion of enveloped viruses in endosomes","volume":"17","author":"White","year":"2016","journal-title":"Traffic"},{"key":"10.1016\/j.antiviral.2019.104701_bib33","doi-asserted-by":"crossref","first-page":"7775","DOI":"10.1128\/JVI.00642-06","article-title":"Role of the stable signal peptide of Junin arenavirus envelope glycoprotein in pH-dependent membrane fusion","volume":"80","author":"York","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib34","doi-asserted-by":"crossref","first-page":"10783","DOI":"10.1128\/JVI.78.19.10783-10792.2004","article-title":"The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex","volume":"78","author":"York","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104701_bib35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/092986711793979733","article-title":"Functional roles of azoles motif in anti-HIV agents","volume":"18","author":"Zhan","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104701_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s13238-018-0604-x","article-title":"Structure-activity relationship optimization for lassa virus fusion inhibitors targeting the transmembrane domain of GP2","volume":"10","author":"Zhang","year":"2019","journal-title":"Protein Cell"},{"key":"10.1016\/j.antiviral.2019.104701_bib37","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.antiviral.2019.03.014","article-title":"Identification of a clinical compound losmapimod that blocks Lassa virus entry","volume":"167","author":"Zhang","year":"2019","journal-title":"Antivir. Res."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930628X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016635421930628X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:31:37Z","timestamp":1759062697000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016635421930628X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":36,"alternative-id":["S016635421930628X"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104701","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The antifungal isavuconazole inhibits the entry of lassa virus by targeting the stable signal peptide-GP2 subunit interface of lassa virus glycoprotein","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104701","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104701"}}